63145
Sulfate de magnésium heptahydraté
tested according to Ph. Eur.
Synonyme(s) :
Sels d’Epsom
Se connecterpour consulter vos tarifs contractuels et ceux de votre entreprise/organisme
About This Item
Formule linéaire :
MgSO4 · 7H2O
Numéro CAS:
Poids moléculaire :
246.47
Numéro CE :
Numéro MDL:
Code UNSPSC :
12161900
eCl@ss :
38030409
ID de substance PubChem :
Produits recommandés
Agence
USP/NF
tested according to Ph. Eur.
Densité de vapeur
<0.01 (vs air)
Pression de vapeur
<0.1 mmHg ( 20 °C)
Chaîne SMILES
O.O.O.O.O.O.O.[Mg++].[O-]S([O-])(=O)=O
InChI
1S/Mg.H2O4S.7H2O/c;1-5(2,3)4;;;;;;;/h;(H2,1,2,3,4);7*1H2/q+2;;;;;;;;/p-2
Clé InChI
WRUGWIBCXHJTDG-UHFFFAOYSA-L
Vous recherchez des produits similaires ? Visite Guide de comparaison des produits
Choose from one of the most recent versions:
Déjà en possession de ce produit ?
Retrouvez la documentation relative aux produits que vous avez récemment achetés dans la Bibliothèque de documents.
Ran D Goldman et al.
Pediatrics, 132(6), e1634-e1641 (2013-11-28)
Vaso-occlusive episodes (VOEs) are the most common complication of sickle cell disease in children. Treatment with magnesium seems to improve cellular hydration and may result in reduced vaso-occlusion. This study aimed to determine if intravenous (IV) magnesium sulfate (MgSO4) reduces
Oluwakemi Badaki-Makun et al.
Pediatric blood & cancer, 61(6), 1049-1054 (2014-01-21)
Multiple recent Sickle Cell Disease studies have been terminated due to poor enrollment. We developed methods to overcome past barriers and utilized these to study the efficacy and safety of intravenous magnesium for vaso-occlusive crisis (VOC). We describe the methods
E S Bain et al.
BJOG : an international journal of obstetrics and gynaecology, 121(5), 595-603 (2014-01-07)
To evaluate a slower (compared with a standard) infusion rate of the loading dose of magnesium sulphate for preterm fetal neuroprotection as a strategy to reduce maternal adverse effects. Randomised controlled trial. South Australian maternity hospital. Fifty-one women at <30
N Arulkumaran et al.
Best practice & research. Clinical obstetrics & gynaecology, 27(6), 877-884 (2013-08-22)
Hypertensive disorders of pregnancy are one of the leading causes of peripartum morbidity and mortality globally. Hypertensive disease in pregnancy is associated with a spectrum of severity, ranging from mild pregnancy-induced hypertension to eclampsia. Although most cases of pre-eclampsia may
Chris Chin
Artificial organs, 37(1), 100-102 (2013-01-12)
Congenital heart disease (CHD) is relatively common and there are treatment options for virtually every form of CHD. With good care, the majority of babies can survive to adulthood; however, CHD remains a significant cause of death in infancy and
Notre équipe de scientifiques dispose d'une expérience dans tous les secteurs de la recherche, notamment en sciences de la vie, science des matériaux, synthèse chimique, chromatographie, analyse et dans de nombreux autres domaines..
Contacter notre Service technique